<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED CONDENSED FINANCIAL STATEMENTS FILED WITH NOVAMED'S SEPTEMBER 30,
2000 QUARTERLY REPORT ON FORM 10-QSB AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0001036478
<NAME> NOVAMED, INC.
<MULTIPLIER> 1
<CURRENCY> U.S. Dollars
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> SEP-30-2000
<EXCHANGE-RATE> 1
<CASH> 0
<SECURITIES> 0
<RECEIVABLES> 186,000
<ALLOWANCES> 0
<INVENTORY> 477,000
<CURRENT-ASSETS> 663,000
<PP&E> 56,000
<DEPRECIATION> 0
<TOTAL-ASSETS> 743,000
<CURRENT-LIABILITIES> 723,000
<BONDS> 0
0
0
<COMMON> 16,000
<OTHER-SE> 4,000
<TOTAL-LIABILITY-AND-EQUITY> 743,000
<SALES> 245,000
<TOTAL-REVENUES> 245,000
<CGS> 116,000
<TOTAL-COSTS> 333,000
<OTHER-EXPENSES> 8,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (80,000)
<INCOME-TAX> 0
<INCOME-CONTINUING> (80,000)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (80,000)
<EPS-BASIC> (0.01)
<EPS-DILUTED> (0.01)
</TABLE>